AstraZeneca lung and breast cancer data at WCLC and ESMO.
The Pharma Data
SEPTEMBER 2, 2021
Durvalumab ± Tremelimumab + Platinum-Etoposide in 1L ES-SCLC: Exploratory Analysis of HLA Genotype and Survival in CASPIAN. A Phase 2 Study of Datopotamab Deruxtecan (Dato-DXd) in Advanced NSCLC With Actionable Genomic Alterations (TROPION-Lung05). Lead author. Abstract title. Presentation details. Immuno-Oncology. Garassino, MC.
52 
Let's personalize your content